Result Summary for 112485
| Protocol ID: | 112485 |
| Clinical Study ID: | 112485 |
| Official Title: | Safety of GlaxoSmithKline (GSK) Biologicals’ human papillomavirus (HPV)-16/18 vaccine, Cervarix® when administered to healthy females according to the prescribing information in Korea |
| Phase: | phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | Human Papillomavirus Types 16 and 18 Vaccine |
| Trade/Product Name: | Cervarix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
